Product Description
The global mechanical heart valve market was valued at $247.9 million in 2025. This is expected to increase at a CAGR of 1.2% to $269.4 million by 2032.
The full report suite on the global market for mechanical heart valves includes prosthetic devices designed to replicate the function of the natural valves of the human heart. The market is also segmented by valve type between aortic, mitral, pulmonary, and tricuspid mechanical valves.
The report includes data for 65 countries across 7 different regions, which include North America, Latin America, Western Europe, Central & Eastern Europe, the Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Mechanical Heart Valve Market Trends
Innovations in biocompatible polymer materials and mechanical valve design have contributed to improved hemocompatibility and reduced thrombogenicity. Modern bileaflet valve designs provide more physiologic blood flow compared to earlier caged-ball or tilting-disc valves, allowing for lower anticoagulation intensity and improved patient outcomes. These advancements have helped slow, but not reverse, the long-term decline of the mechanical heart valve market.
Global Mechanical Heart Valve Market Share Insights
- Abbott was the leading competitor in the mechanical heart valve market. Abbott offers its Masters HP™ and Regent™ mechanical heart valves. Abbott’s mechanical heart valves are offered in sizes ranging from 19 mm to 29 mm. Masters HP™ has a 15-mm option for use in pediatric surgery. The mechanical heart valve market is contradictory, resulting in a limited number of companies in the area. It is expected that Abbott may lose some shares as they shift focus to expanding markets.
- Artivion was the second-leading competitor in the market. The company provides its Conform-X™, Anatomic™, and Standard™ mechanical heart valves. The company has a limited portfolio, allowing it to focus on the core patient pool for mechanical heart valves. For this reason, it will see growth in the overall share of the market it holds by the end of the forecast
- Corcym was the third-leading company in the mechanical heart valve market. The Carbomedics™ line of mechanical valves is available for aortic and mitral valves. The valves are available in sizes ranging from 19 mm to 33 mm. The company has a limited portfolio that focuses on heart valves. For this reason, it will see growth in the overall share of the market it holds by the end of the forecast
Global Mechanical Heart Valve Market Segmentation Summary
- Mechanical Heart Valve Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
